Active Ingredient History

NOW
  • Now
Lurtotecan is a semi-synthetic analog of camptothecin with antineoplastic activity. Liposomal lurtotecan was in clinical trials as a treatment for topotecan-resistant ovarian cancer, but was discontinued.   Wikipedia

More Chemistry
7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(s)-camptothecin | gg211 | gg-211 | gi147211 | gi 147211 | gi-147211 | gl147211c | gl 147211c | gl-147211c | lurtotecan | nx 211 | nx-211 | nx211 cpd | osi211 | osi 211 | osi-211

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue